Temecula, California Clinical Trials

Asthma

Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Asthma

Bipolar Disorder

Investigative Site 017

Patients are needed to participate in a clinical research study of cariprazine and placebo to evaluate Bipolar Disorder or Depression

Chronic Pain

Research Site

Patients are needed to participate in a clinical research study evaluating AXS-02 (oral zoledronate) and Placebo for the treatment of Chronic Regional Pain Syndrome - Type 1 or Reflex Sympathetic Dystrophy (crps-1)

Dementia

Research Site

Patients are needed to participate in a clinical research study evaluating AVP-786 for the treatment of Agitation in Alzheimer's Disease

Research Site

Patients are needed to participate in a clinical research study of AVP-786 and Placebo to evaluate Agitation in Patients With Dementia of the Alzheimer's Type

Depression

Research Site

A clinical trial to evaluate treatments using AXS-05 and Bupropion for patients with Treatment Resistant Major Depressive Disorder

Investigative Site 017

Patients are needed to participate in a clinical research study of cariprazine and placebo to evaluate Bipolar Disorder or Depression

Viking Clinical Research Updated

Patients are needed to participate in a clinical research study of Rapastinel to evaluate Depressive Disorder, Major

Viking Clinical Research

A clinical trial to evaluate treatments using Rapastinel and Placebo for patients with Depressive Disorder, Major

Viking Clinical Research Updated

Patients are needed to participate in a clinical research study of Rapastinel and Placebo-matching Rapastinel to evaluate Depressive Disorder, Major

Multiple Sclerosis

Viking Clinical Research Center

A clinical study for patients with Multiple Sclerosis

Post-Traumatic Stress Disorders

Temecula

A clinical research study of TNX-102 SL and Placebo SL Tablet for the treatment of PTSD

Schizophrenia and Schizoaffective Disorders

Alkermes Investigational Site

Patients are needed to participate in a clinical research study of ALKS 3831 and Olanzapine to evaluate Schizophrenia